Nav: Home

Fluorescent probes offer fuller view of drug delivery in cells

November 01, 2019

Selecting the most effective molecules for drug delivery is often a trial-and-error process, but Cornell engineers are providing some precision thanks to a technique that reveals the performance of those molecules inside living cells.

Drug delivery systems control the time and place therapeutics are released inside the body. An essential component of many drug delivery systems is the molecule that links an antibody - which seeks out a target such as cancer cells - to a drug designed to destroy the target. The linker must not only keep the drug tethered to the antibody as it travels to a targeted cell, it must properly release the drug inside the cell, in the right place at the right time.

Biomolecular engineers gather clues about linkers' effectiveness by testing them in cell-free environments - model fluids that don't contain all the complex interactions typically found in whole, living cells. They're easier to study, but aren't always as accurate, potentially leading to linker failure in subsequent testing.

A research team led by Chris Alabi, associate professor of chemical and biomolecular engineering, has developed a method that employs fluorescent probes to see and measure the rate at which linkers successfully release drugs in living cells. The research, "Responsive Antibody Conjugates Enable Quantitative Determination of Intracellular Bond Degradation Rate," published Oct. 8 in the journal Cell Chemical Biology.

"Right now, pharmaceutical companies make a ton of linkers and then see which functions best for a particular application by having to test each one. It's a shotgun approach," Alabi said. "With our technique, they can now make an informed decision based on actual intracellular numbers, before they put the drug system together."

The probes consist of two fluorescent dyes that render each other invisible when they're tethered together with the antibody as part of the delivery system. When the linker breaks and untethers the dyes, they become visible using a microscope, signaling the drug has been released inside the cell.

These probes were developed in Alabi's lab and offer engineers an accurate way to measure the rate at which a linker's chemical bond breaks from the delivery system while inside the cell.

"Once we know what the timing is for different linker bonds and cell processes, then we can say, 'OK, for drug A connected to antibody B, this is how long it will take, so if we want to treat disease C, we should use this linker,'" Alabi said.

To demonstrate the probe, Alabi and his team engineered an antibody construct with a disulfide linker known to work well within the HER2 protein, a highly valued target for breast cancer treatment. Once the delivery system reached the protein, the team was able to reliably measure intracellular processes, such as the kinetics and half-life of the disulfide linker.

"For the biomolecular engineers and companies that have a target in mind, we can ... make the drug discovery process that much faster because we now know something about how long it's going to take to release the drug," said Alabi, who hopes to demonstrate the technique further through partnerships with pharmaceutical companies.

The probes can also be used by chemical biologists to learn more about intracellular processes, such as the specific agents responsible for cleaving linkers, Alabi said.
-end-
The work was supported by funds from Cornell and the Nancy and Peter Meinig Investigator Fellowship.

Cornell University

Related Drug Delivery Articles:

Microcapsules for targeted drug delivery to cancer cells
A team of scientists from Peter the Great St. Petersburg Polytechnic University together with their colleagues developed a method of targeted drug delivery to cancer cells.
Improving drug delivery for brain tumor treatment
Despite improvements in drug delivery mechanisms, treating brain tumors has remained challenging.
Nanoparticle orientation offers a way to enhance drug delivery
MIT engineers have shown that they can enhance the performance of drug-delivery nanoparticles by controlling an inherent trait of chemical structures, known as chirality -- the 'handedness' of the structure.
News about drug delivery
Nanocontainer for drugs can have their pitfalls: If they are too heavily loaded, they will only dissolve poorly.
Deflating beach balls and drug delivery
Gwennou Coupier and his colleagues at Grenoble Alps University, Grenoble, France have shown that macroscopic-level models of the properties of microscopic hollow spheres agree very well with theoretical predictions.
New way to wrap liquid drops could improve drug delivery
Researchers have developed a faster, cheaper way to coat liquid medication, an invention that could improve how drugs are delivered in the body.
Nanomesh drug delivery provides hope against global antibiotic resistance
Flinders University researchers and collaborators in Japan have produced a nanomesh that is capable of delivering drug treatments.
More efficient drug delivery within the brain by utilizing LAT1
According to a new study carried out at the University of Eastern Finland, the distribution of drug molecules within the brain can be improved by utilizing LAT1, which is expressed highly in the brain.
Researchers improve drug delivery through mesoporous materials
In a paper to be published in the forthcoming issue in NANO, a group of researchers from Guiyang, China, have conducted a study based on previous experimental research on DOX as a model drug and introduced a reverse method in which organic groups are grafted after removing the template agent.
Charcoal-based drug delivery system improves efficacy of common herpes drug
A study led by researchers from the University of Illinois at Chicago has found that combining acyclovir -- a commonly prescribed topical herpes medication -- with particles of activated carbon improves efficacy of the drug.
More Drug Delivery News and Drug Delivery Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Climate Mindset
In the past few months, human beings have come together to fight a global threat. This hour, TED speakers explore how our response can be the catalyst to fight another global crisis: climate change. Guests include political strategist Tom Rivett-Carnac, diplomat Christiana Figueres, climate justice activist Xiye Bastida, and writer, illustrator, and artist Oliver Jeffers.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Speedy Beet
There are few musical moments more well-worn than the first four notes of Beethoven's Fifth Symphony. But in this short, we find out that Beethoven might have made a last-ditch effort to keep his music from ever feeling familiar, to keep pushing his listeners to a kind of psychological limit. Big thanks to our Brooklyn Philharmonic musicians: Deborah Buck and Suzy Perelman on violin, Arash Amini on cello, and Ah Ling Neu on viola. And check out The First Four Notes, Matthew Guerrieri's book on Beethoven's Fifth. Support Radiolab today at Radiolab.org/donate.